Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial

Atherosclerotic cardiovascular disease (ASCVD) events, including coronary heart disease and stroke, are the most frequent cause of death and major disability in the world. Current American College of Cardiology/American Heart Association primary prevention guidelines are mainly on the basis of rando...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2015-10, Vol.66 (16), p.1828-1836
Hauptverfasser:	Domanski, Michael J, Fuster, Valentin, Diaz-Mitoma, Francisco, Grundy, Scott, Lloyd-Jones, Donald, Mamdani, Muhammad, Roberts, Robin, Thorpe, Kevin, Hall, Judith, Udell, Jacob A, Farkouh, Michael E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Asymptomatic Diseases Cholesterol, LDL - blood Cholesterol, LDL - drug effects Coronary Disease - blood Coronary Disease - epidemiology Coronary Disease - prevention & control Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Patient Selection Plaque, Atherosclerotic - prevention & control Primary Prevention - methods Randomized Controlled Trials as Topic Research Design Risk Assessment Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!